HTG Molecular Diagnostics Profit Margin 2014-2018 | HTGM
Current and historical gross margin, operating margin and net profit margin for HTG Molecular Diagnostics (HTGM) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. HTG Molecular Diagnostics net profit margin as of December 31, 2018 is -76.52%.
|HTG Molecular Diagnostics Annual Profit Margins
|HTG Molecular Diagnostics Quarterly Profit Margins
||Medical Instruments Manufacturing
HTG Molecular Diagnostics, Inc. is engaged in developing and marketing a technology platform which consists of instrumentation, consumables and software analytics for sample profiling applications including tumor profiling, molecular diagnostic testing and biomarker development. Its products include HTG Edge System, HTG Edge Assays and HTG Assay Direct. HTG Molecular Diagnostics, Inc. is headquartered in Tucson, Arizona.